ArticleScientific reports2026
Benchmarking the prediction of responding cells to perturbations affecting both gene expression and cellular abundance using scRNA sequencing.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Defining how cells respond to perturbations is crucial for understanding their biology. While previous works were designed to classify responding cells, methods for quantifying the response of each cell are not well developed. In addition, perturbations affecting only gene expression were considered for modeling. However, perturbation not only alters the gene expression of cells but also alters cellular abundance. But to date, no validation data is available to assess such perturbations. To address this issue, we utilized the clonal expansion of T or B cells as a new validation data type that can accompany both gene expression and alterations in cellular abundance after perturbation. Subsequently, we developed BRiCE, a new benchmark pipeline for assessing RC and Res, where RC refers to how well it can distinguish the responding cells against non-responding cells, while Res refers to how well it can quantify the responsiveness, and compares its performance with that of preexisting methods. However, none of the existing methods demonstrated predictive power. These results indicated that the current approach to understanding perturbation solely by gene expression is insufficient, and cellular abundance must be considered in perturbation modeling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.